๐ฐ Cochlear Ltd News
Page 12 - Cochlear Ltd News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cochlear Ltd. Real-time updates on events, politics, business and more.
September 1, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
August 24, 2022
/PRNewswire/ -- The global hearing aid market is expected to grow by USD 3.72 billion from 2020 to 2025, progressing at a CAGR of 7.73 % according to...
August 16, 2022
Once considered an inconvenience of getting older, age-related hearing loss has emerged as a critical public health issue.
August 9, 2022
/PRNewswire/ -- The "The Market for Neurotechnology: 2022-2026" report has been added to ResearchAndMarkets.coms offering. Overall worldwide market for...
August 3, 2022
The Business Research Companyโs Neuroprosthetics Global Market Report 2022 โ Market Size, Trends, And Global Forecast 2022-2026
July 22, 2022
Fort Myers-based NeoGenomics has appointed a new CEO after a months-long search.
July 14, 2022
DUBLIN--(BUSINESS WIRE)--The "Active Implantable Medical Devices Market Research Report by Product, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.The Global Active Implantable Medical Devices Market size was estimated at USD 2,0...
July 6, 2022
Surge in cases of hearing disability among the children and elderly population across the globe is a major factor fuelling growth.Future Market Insights (FMI) has projected the hearing implants market to register impressive growth at 7.3% CAGR during the forecast period. Hearing implant market valuation will surpass...
July 1, 2022
Australian approval follows recent trial approval by regulatory authorities in France Regulatory News: Sensorion (FR0012596468 ALSEN), a pioneering clinical-stage biotechnology company which
July 1, 2022
Australian approval follows recent trial approval by regulatory authorities in FranceMONTPELLIER, France--(BUSINESS WIRE)--Regulatory News:Sensorion (FR0012596468 โ ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within t...